Healthcare ❯Pharmaceuticals ❯Vaccines

COVID-19 Vaccines

Protein-based Vaccines Novavax

Novavax Shares Fall as Revenue Forecast Slashed Again

Novavax Lowers 2024 Revenue Forecast, Reduces European Operations